![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ETHE1 |
Gene summary for ETHE1 |
![]() |
Gene information | Species | Human | Gene symbol | ETHE1 | Gene ID | 23474 |
Gene name | ETHE1 persulfide dioxygenase | |
Gene Alias | HSCO | |
Cytomap | 19q13.31 | |
Gene Type | protein-coding | GO ID | GO:0006518 | UniProtAcc | A0A0S2Z580 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23474 | ETHE1 | LZE8T | Human | Esophagus | ESCC | 9.83e-09 | 1.00e-01 | 0.067 |
23474 | ETHE1 | LZE22T | Human | Esophagus | ESCC | 2.35e-02 | 1.83e-01 | 0.068 |
23474 | ETHE1 | LZE24T | Human | Esophagus | ESCC | 3.72e-20 | 7.25e-01 | 0.0596 |
23474 | ETHE1 | LZE6T | Human | Esophagus | ESCC | 1.26e-10 | 3.35e-01 | 0.0845 |
23474 | ETHE1 | P1T-E | Human | Esophagus | ESCC | 3.26e-17 | 1.18e+00 | 0.0875 |
23474 | ETHE1 | P2T-E | Human | Esophagus | ESCC | 3.93e-09 | 1.29e-01 | 0.1177 |
23474 | ETHE1 | P4T-E | Human | Esophagus | ESCC | 1.33e-35 | 7.40e-01 | 0.1323 |
23474 | ETHE1 | P5T-E | Human | Esophagus | ESCC | 1.16e-44 | 1.35e+00 | 0.1327 |
23474 | ETHE1 | P8T-E | Human | Esophagus | ESCC | 1.53e-26 | 7.55e-01 | 0.0889 |
23474 | ETHE1 | P9T-E | Human | Esophagus | ESCC | 3.01e-16 | 5.14e-01 | 0.1131 |
23474 | ETHE1 | P10T-E | Human | Esophagus | ESCC | 4.10e-36 | 8.88e-01 | 0.116 |
23474 | ETHE1 | P11T-E | Human | Esophagus | ESCC | 6.60e-23 | 1.12e+00 | 0.1426 |
23474 | ETHE1 | P12T-E | Human | Esophagus | ESCC | 1.18e-53 | 1.33e+00 | 0.1122 |
23474 | ETHE1 | P15T-E | Human | Esophagus | ESCC | 5.25e-27 | 7.78e-01 | 0.1149 |
23474 | ETHE1 | P16T-E | Human | Esophagus | ESCC | 8.88e-09 | 7.59e-02 | 0.1153 |
23474 | ETHE1 | P17T-E | Human | Esophagus | ESCC | 1.05e-14 | 1.05e+00 | 0.1278 |
23474 | ETHE1 | P19T-E | Human | Esophagus | ESCC | 7.20e-11 | 6.50e-01 | 0.1662 |
23474 | ETHE1 | P20T-E | Human | Esophagus | ESCC | 4.76e-29 | 7.33e-01 | 0.1124 |
23474 | ETHE1 | P21T-E | Human | Esophagus | ESCC | 2.76e-31 | 8.29e-01 | 0.1617 |
23474 | ETHE1 | P22T-E | Human | Esophagus | ESCC | 3.98e-42 | 9.45e-01 | 0.1236 |
Page: 1 2 3 4 5 6 7 8 9 10 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0006790 | Colorectum | AD | sulfur compound metabolic process | 101/3918 | 339/18723 | 6.46e-05 | 1.07e-03 | 101 |
GO:0006575 | Colorectum | AD | cellular modified amino acid metabolic process | 59/3918 | 188/18723 | 4.80e-04 | 5.27e-03 | 59 |
GO:00067901 | Colorectum | SER | sulfur compound metabolic process | 73/2897 | 339/18723 | 1.75e-03 | 1.81e-02 | 73 |
GO:00065751 | Colorectum | MSS | cellular modified amino acid metabolic process | 55/3467 | 188/18723 | 2.16e-04 | 3.01e-03 | 55 |
GO:00067902 | Colorectum | MSS | sulfur compound metabolic process | 85/3467 | 339/18723 | 1.52e-03 | 1.39e-02 | 85 |
GO:00067906 | Esophagus | ESCC | sulfur compound metabolic process | 201/8552 | 339/18723 | 2.64e-07 | 3.94e-06 | 201 |
GO:00065757 | Esophagus | ESCC | cellular modified amino acid metabolic process | 112/8552 | 188/18723 | 8.31e-05 | 6.06e-04 | 112 |
GO:000674912 | Esophagus | ESCC | glutathione metabolic process | 42/8552 | 64/18723 | 1.01e-03 | 5.12e-03 | 42 |
GO:000679011 | Liver | Cirrhotic | sulfur compound metabolic process | 129/4634 | 339/18723 | 3.06e-08 | 1.04e-06 | 129 |
GO:000657511 | Liver | Cirrhotic | cellular modified amino acid metabolic process | 70/4634 | 188/18723 | 9.04e-05 | 9.69e-04 | 70 |
GO:00067494 | Liver | Cirrhotic | glutathione metabolic process | 27/4634 | 64/18723 | 1.63e-03 | 1.05e-02 | 27 |
GO:000679021 | Liver | HCC | sulfur compound metabolic process | 212/7958 | 339/18723 | 5.60e-14 | 3.39e-12 | 212 |
GO:000657521 | Liver | HCC | cellular modified amino acid metabolic process | 119/7958 | 188/18723 | 6.47e-09 | 1.67e-07 | 119 |
GO:000674911 | Liver | HCC | glutathione metabolic process | 44/7958 | 64/18723 | 1.95e-05 | 2.09e-04 | 44 |
GO:00067905 | Oral cavity | OSCC | sulfur compound metabolic process | 168/7305 | 339/18723 | 4.50e-05 | 3.84e-04 | 168 |
GO:00065756 | Oral cavity | OSCC | cellular modified amino acid metabolic process | 91/7305 | 188/18723 | 5.33e-03 | 2.07e-02 | 91 |
GO:000657512 | Oral cavity | LP | cellular modified amino acid metabolic process | 64/4623 | 188/18723 | 2.43e-03 | 1.73e-02 | 64 |
GO:000679012 | Oral cavity | LP | sulfur compound metabolic process | 106/4623 | 339/18723 | 3.36e-03 | 2.25e-02 | 106 |
GO:00065758 | Skin | cSCC | cellular modified amino acid metabolic process | 73/4864 | 188/18723 | 7.11e-05 | 6.85e-04 | 73 |
GO:00067498 | Skin | cSCC | glutathione metabolic process | 26/4864 | 64/18723 | 7.34e-03 | 3.47e-02 | 26 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa009202 | Colorectum | SER | Sulfur metabolism | 8/1580 | 10/8465 | 4.56e-05 | 5.22e-04 | 3.79e-04 | 8 |
hsa009203 | Colorectum | SER | Sulfur metabolism | 8/1580 | 10/8465 | 4.56e-05 | 5.22e-04 | 3.79e-04 | 8 |
hsa009208 | Colorectum | CRC | Sulfur metabolism | 5/1091 | 10/8465 | 5.07e-03 | 2.72e-02 | 1.84e-02 | 5 |
hsa009209 | Colorectum | CRC | Sulfur metabolism | 5/1091 | 10/8465 | 5.07e-03 | 2.72e-02 | 1.84e-02 | 5 |
hsa0092010 | Esophagus | ESCC | Sulfur metabolism | 9/4205 | 10/8465 | 1.01e-02 | 2.38e-02 | 1.22e-02 | 9 |
hsa0092011 | Esophagus | ESCC | Sulfur metabolism | 9/4205 | 10/8465 | 1.01e-02 | 2.38e-02 | 1.22e-02 | 9 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ETHE1 | SNV | Missense_Mutation | c.367N>T | p.Gly123Trp | p.G123W | O95571 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A2-A04T-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | SD | |
ETHE1 | SNV | Missense_Mutation | novel | c.640C>T | p.Arg214Trp | p.R214W | O95571 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-EA-A3HU-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
ETHE1 | SNV | Missense_Mutation | c.583N>T | p.His195Tyr | p.H195Y | O95571 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-IR-A3LL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
ETHE1 | SNV | Missense_Mutation | rs28940289 | c.487N>T | p.Arg163Trp | p.R163W | O95571 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-3877-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ETHE1 | SNV | Missense_Mutation | novel | c.678N>A | p.Met226Ile | p.M226I | O95571 | protein_coding | deleterious(0) | possibly_damaging(0.592) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
ETHE1 | SNV | Missense_Mutation | rs779584627 | c.641N>A | p.Arg214Gln | p.R214Q | O95571 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ETHE1 | SNV | Missense_Mutation | c.437A>G | p.Asp146Gly | p.D146G | O95571 | protein_coding | deleterious(0.03) | benign(0.25) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ETHE1 | SNV | Missense_Mutation | rs772537157 | c.356N>T | p.Ser119Phe | p.S119F | O95571 | protein_coding | tolerated(0.07) | benign(0.003) | TCGA-EO-A22T-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ETHE1 | SNV | Missense_Mutation | novel | c.464N>T | p.Ala155Val | p.A155V | O95571 | protein_coding | deleterious(0.01) | possibly_damaging(0.545) | TCGA-EO-A22X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unspecific | Carboplatin | Complete Response |
ETHE1 | SNV | Missense_Mutation | novel | c.571N>T | p.Ile191Phe | p.I191F | O95571 | protein_coding | deleterious(0) | possibly_damaging(0.529) | TCGA-44-5645-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |